Skip to main content
HomeDrug Comparisons
Drug bottle and Pill

Compare Beyfortus vs. Arexvy

Head-to-head comparisons of medication uses, side effects, warnings, and more.

  • Beyfortus (nirsevimab)
    Arexvy (RSV vaccine)
  • Beyfortus (nirsevimab)
    Arexvy (RSV vaccine)

  • Summary of Beyfortus vs. Arexvy

    Summary for Monoclonal antibody
    Prescription only

    Beyfortus (nirsevimab or nirsevimab-alip) is an injection given to babies and children up to 24 months old. It's used to prevent them from getting very sick from respiratory syncytial virus (RSV). It's not an RSV vaccine. Instead, it's a monoclonal antibody that gives protection against the virus for a short time. Beyfortus (nirsevimab) is now part of the CDC Child Immunization Schedule. The usual dosage is 1 to 2 injections into the muscle during or at the start of the RSV season. It's well-tolerated with only a few side effects.

    Summary for Vaccine
    Prescription only

    Arexvy (RSV vaccine) is the first FDA-approved vaccine to help lower your risk of getting serious lung infections caused by respiratory syncytial virus (RSV). You can get it if you're age 60 or older, and in some cases starting at age 18 if you have a higher risk of severe illness from RSV. Arexvy (RSV vaccine) is given once as a single injection into the muscle. Common side effects include tiredness, muscle pain, and injection site reactions like pain, swelling, or redness.

  • Indications of Beyfortus vs. Arexvy

    Indications for
    •Prevention of respiratory syncytial virus (RSV) in young children of certain ages
    •Newborns and infants born during or entering their first RSV season
    •Children up to 24 months old at risk of severe RSV illness through their second RSV season
    Indications for

    Prevention of serious lung infections caused by respiratory syncytial virus (RSV) in:

    •Adults 60 years and older
    •Adults 18 to 59 years old who have a higher risk of illness due to RSV

  • Pros and Cons of Beyfortus vs. Arexvy

    Pros and Const for Monoclonal antibody
    Pros
    •Given during one medical visit
    •Can lower the risk of severe RSV-related illness by about 70% in full-term and premature babies
    •Not many side effects
    Cons
    •Injection can be uncomfortable
    •Protection might only last for about 5 months
    •Not known if it's safe or if it works well for children older than 24 months
    Pros and Const for Vaccine
    Pros
    •Reduces the risk of RSV-related lung infections
    •Only need one dose
    •Can be given with other vaccines
    Cons
    •Injection might be uncomfortable
    •Common side effects include tiredness and muscle pain
    •Not approved for use in pregnancy

  • Common Side Effects of Beyfortus vs. Arexvy

    Common Side Effects for
    •Side effects aren't common. See Other Side Effects.
    Common Side Effects for

    18 to 49 years old:

    •Pain at the injection site (76%)
    •Muscle pain (60%)
    •Tiredness (60%)
    •Headache (44%)
    •Joint pain (28%)

    50 to 59 years old:

    •Pain at the injection site (76%)
    •Tiredness (40%)
    •Muscle pain (36%)
    •Headache (32%)
    •Joint pain (23%)

    60 years and older:

    •Pain at the injection site (61%)
    •Tiredness (34%)
    •Muscle pain (29%)
    •Headache (27%)
    •Joint pain (18%)

  • Warnings of Beyfortus vs. Arexvy

    Common Side Effects for
    •Severe allergic reaction
    •Caution use in children with bleeding problems
    Common Side Effects for
    •Guillain-Barré syndrome
    •Severe allergic reaction
    •Fainting
    •Weaker vaccine protection

  • Prices with our coupons for Beyfortus vs. Arexvy

    Learn more about Beyfortus
    Learn more about Arexvy

Compare other RSV drugs

Beyfortus vs AbrysvoBeyfortus vs ArexvyArexvy vs AbrysvoMresvia vs Arexvy

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.